Definitive Contract 75N91021C00003
Award Date
12/23/20
Potential Completion Date
12/22/23
Potential Value
$2.7M
Federal Agency
National Cancer Institute
Ultimate Awardee
Not listed
PSC Category
B537 - Special Studies/Analysis- Medical/Health
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
New York, NY 10029, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Davis Bacon Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to the Icahn School of Medicine at Mount Sinai (ISMMS) was made by the National Institute of Allergy and Infectious Diseases (NIAID) to conduct research on "Modeling Immunity for Biodefense". The $17,219,467.21 cost-no-fee contract has a period of performance from September 30, 2010 to September 29, 2015 and does not have a set-aside designation. Under this award, ISMMS is collaborating with several subcontractors, including the California Institute of...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the Icahn School of Medicine at Mount Sinai (ISMMS), a private university and non-profit educational institution. The $10,799,605.00 Definitive Contract is for BIOMEDICAL (BASIC) services, with a Firm Fixed Price pricing type. The contract has no set-aside designation and was awarded on August 17, 2009, with a completion date of September...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the Icahn School of Medicine at Mount Sinai (ISMMS), a private academic medical center and research institution located in New York, NY. The $18,691,713.00 cost-no-fee definitive contract is for biomedical research services, with a period of performance ending on March 31, 2011. The contract does not have a set-aside designation....
The National Cancer Institute (NCI) awarded a $166,410.58 firm fixed-price purchase order to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The purpose is to procure 620 samples for NCI's Multi-Ancestry Genome-Wide Association Study, with a period of performance from September 25, 2022 through September 24, 2023, and an ultimate completion date of September 25, 2025. This contract has no set-aside designation. Sloan-Kettering Institute for Cancer Research is a...
This federal contract award is to the Icahn School of Medicine at Mount Sinai (ISMMS), a renowned academic medical center and research institution in New York City. The contract, valued at $399,266.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to support the development of animal models of infectious diseases. The award is a delivery order under NIAID's larger "Animal Models of Infectious Diseases...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $36,735.52 firm fixed price purchase order to the Sloan-Kettering Institute for Cancer Research, a non-profit organization focused on cancer research and patient care located in New York, NY. The contract is for a scientific investigator with a Ph.D. in biosciences to conclude a study on FAS modulation, cell fate, and its relation to human disease for the NIAMS Autoimmunity...
This is a $128,680,006.00 definitive, cost no fee federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the Icahn School of Medicine at Mount Sinai. The contract will support the NIAID Centers of Excellence for Influenza Research and Response (CEIRR), a multi-disciplinary collaborative network focused on influenza research. The contract was not set aside for any specific business type. The Icahn School of Medicine at Mount Sinai is a prominent...
This is a definitive contract awarded by the Department of the Army's Research, Development and Engineering Command (RDECOM) to the Icahn School of Medicine at Mount Sinai (ISMMS), a renowned academic medical center and research institution located in New York City. The contract, valued at $1,041,139.74, was awarded on February 1, 2024, and has a completion date of February 28, 2025. The purpose of this contract is to develop and standardize an assay for evaluating immunomodulatory activities of...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract is part of the NCI Cancer Genome Atlas Program and is valued at $174,500.00. It involves the collection of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The contract has no set-aside...
This is a federal contract award from the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $7,053,827.00, was awarded to the University of Maryland, Baltimore (UMB) to serve as a resource for the collection of human tissue, cells, biofluids, and epidemiologic profiles from donors to support NCI's Laboratory of Human Carcinogenesis research programs. The contract has a 1-year base period and four 1-year option...